Historical  ||| S:0 E:11 ||| JJ
perspective  ||| S:11 E:23 ||| NN
on  ||| S:23 E:26 ||| IN
antipsychotic  ||| S:26 E:40 ||| JJ
long-acting  ||| S:40 E:52 ||| JJ
injections  ||| S:52 E:63 ||| NNS
Clinical  ||| S:63 E:72 ||| JJ
experience  ||| S:72 E:83 ||| NN
has  ||| S:83 E:87 ||| VBZ
shown  ||| S:87 E:93 ||| VBN
considerable  ||| S:93 E:106 ||| JJ
potential  ||| S:106 E:116 ||| JJ
benefits  ||| S:116 E:125 ||| NNS
from  ||| S:125 E:130 ||| IN
long-term  ||| S:130 E:140 ||| JJ
continuous  ||| S:140 E:151 ||| JJ
medication  ||| S:151 E:162 ||| NN
for  ||| S:162 E:166 ||| IN
chronic  ||| S:166 E:174 ||| JJ
or  ||| S:174 E:177 ||| CC
relapsing  ||| S:177 E:187 ||| JJ
forms  ||| S:187 E:193 ||| NNS
of  ||| S:193 E:196 ||| IN
schizophrenia ||| S:196 E:209 ||| NN
.  ||| S:209 E:211 ||| .
These  ||| S:211 E:217 ||| DT
benefits  ||| S:217 E:226 ||| NNS
have  ||| S:226 E:231 ||| VBP
not  ||| S:231 E:235 ||| RB
always  ||| S:235 E:242 ||| RB
been  ||| S:242 E:247 ||| VBN
realised ||| S:247 E:255 ||| NN
.  ||| S:255 E:257 ||| .
To  ||| S:257 E:260 ||| TO
review  ||| S:260 E:267 ||| VB
the  ||| S:267 E:271 ||| DT
research  ||| S:271 E:280 ||| NN
literature  ||| S:280 E:291 ||| NN
in  ||| S:291 E:294 ||| IN
order  ||| S:294 E:300 ||| NN
to  ||| S:300 E:303 ||| TO
understand  ||| S:303 E:314 ||| VB
the  ||| S:314 E:318 ||| DT
problems  ||| S:318 E:327 ||| NNS
of  ||| S:327 E:330 ||| IN
long-term  ||| S:330 E:340 ||| JJ
medication  ||| S:340 E:351 ||| NN
and  ||| S:351 E:355 ||| CC
use  ||| S:355 E:359 ||| NN
of  ||| S:359 E:362 ||| IN
antipsychotic  ||| S:362 E:376 ||| JJ
oral  ||| S:376 E:381 ||| JJ
medication  ||| S:381 E:392 ||| NN
and  ||| S:392 E:396 ||| CC
long-acting  ||| S:396 E:408 ||| JJ
injections  ||| S:408 E:419 ||| NNS
( ||| S:419 E:420 ||| -LRB-
LAIs ||| S:420 E:424 ||| NNP
) ||| S:424 E:425 ||| -RRB-
,  ||| S:425 E:427 ||| ,
and  ||| S:427 E:431 ||| CC
to  ||| S:431 E:434 ||| TO
place  ||| S:434 E:440 ||| VB
these  ||| S:440 E:446 ||| DT
in  ||| S:446 E:449 ||| IN
an  ||| S:449 E:452 ||| DT
historical  ||| S:452 E:463 ||| JJ
context ||| S:463 E:470 ||| NN
.  ||| S:470 E:472 ||| .
Review  ||| S:472 E:479 ||| NN
of  ||| S:479 E:482 ||| IN
literature ||| S:482 E:492 ||| NN
.  ||| S:492 E:494 ||| .
Research  ||| S:494 E:503 ||| NNP
showed  ||| S:503 E:510 ||| VBD
that  ||| S:510 E:515 ||| IN
the  ||| S:515 E:519 ||| DT
potential  ||| S:519 E:529 ||| JJ
success  ||| S:529 E:537 ||| NN
of  ||| S:537 E:540 ||| IN
LAI  ||| S:540 E:544 ||| NNP
therapy  ||| S:544 E:552 ||| NN
depends  ||| S:552 E:560 ||| VBZ
on  ||| S:560 E:563 ||| IN
the  ||| S:563 E:567 ||| DT
quality  ||| S:567 E:575 ||| NN
of  ||| S:575 E:578 ||| IN
the  ||| S:578 E:582 ||| DT
follow-up  ||| S:582 E:592 ||| JJ
service ||| S:592 E:599 ||| NN
.  ||| S:599 E:601 ||| .
Following  ||| S:601 E:611 ||| VBG
the  ||| S:611 E:615 ||| DT
advent  ||| S:615 E:622 ||| NN
of  ||| S:622 E:625 ||| IN
second-generation  ||| S:625 E:643 ||| JJ
oral  ||| S:643 E:648 ||| JJ
antipsychotics  ||| S:648 E:663 ||| JJ
confidence  ||| S:663 E:674 ||| NN
in  ||| S:674 E:677 ||| IN
the  ||| S:677 E:681 ||| DT
use  ||| S:681 E:685 ||| NN
of  ||| S:685 E:688 ||| IN
LAIs  ||| S:688 E:693 ||| NNP
has  ||| S:693 E:697 ||| VBZ
eroded  ||| S:697 E:704 ||| VBN
and  ||| S:704 E:708 ||| CC
that  ||| S:708 E:713 ||| IN
mistakes  ||| S:713 E:722 ||| NNS
made  ||| S:722 E:727 ||| VBN
in  ||| S:727 E:730 ||| IN
LAI  ||| S:730 E:734 ||| NNP
use  ||| S:734 E:738 ||| NN
during  ||| S:738 E:745 ||| IN
the  ||| S:745 E:749 ||| DT
past  ||| S:749 E:754 ||| JJ
century  ||| S:754 E:762 ||| NN
may  ||| S:762 E:766 ||| MD
be  ||| S:766 E:769 ||| VB
repeated ||| S:769 E:777 ||| VBN
.  ||| S:777 E:779 ||| .
